46 Significant reduction of second breast cancer risk in patients treated with involved nodes radiation therapy for early stage Hodgkin's lymphoma
Andrea Riccardo Filippi(University of Turin), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Angela Botticella(Azienda Ospedaliero Universitaria San Giovanni Battista), C. Fiandra(University of Turin), Riccardo Ragona, Alessandro Levis(San Antonio College), Massimo Federico, Umberto Vitolo(Candiolo Cancer Institute), Ercole Brusamolino(University of Pavia), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia)
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646